C M Mendel Selected Research

Obesity

9/2001

Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C M Mendel Research Topics

Disease

4	Weight Loss (Weight Reduction) 01/2002 - 07/2000
3	Hypertension (High Blood Pressure) 01/2002 - 07/2000
2	Body Weight (Weight, Body) 09/2001 - 07/2000
2	Dyslipidemias (Dyslipidemia) 09/2001 - 09/2001
1	Tuberculosis (Tuberculoses) 10/2018
1	Type 2 Diabetes Mellitus (MODY) 09/2001
1	Obesity 09/2001
1	Overweight 09/2001
1	Confusion (Bewilderment) 01/2000

Drug/Important Bio-Agent (IBA)

5	sibutramine (Meridia)FDA Link 01/2002 - 01/2000
3	Triglycerides (Triacylglycerol)IBA 01/2002 - 07/2000
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2002 - 07/2000
2	HDL CholesterolIBA 09/2001 - 07/2000
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2001 - 07/2000
1	Moxifloxacin (Avelox)FDA Link 10/2018
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2002
1	Serotonin (5 Hydroxytryptamine)IBA 01/2002
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 01/2002
1	VLDL CholesterolIBA 01/2002
1	LipidsIBA 09/2001
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2001
1	Uric Acid (Urate)IBA 07/2000
1	CholesterolIBA 07/2000
1	Glucose (Dextrose)FDA LinkGeneric 07/2000
1	oxidized low density lipoproteinIBA 07/2000
1	LDL CholesterolIBA 07/2000